Interestingly, a study reported that diabetes-induced synaptic impairment in the hippocampus of mice can be protected by inhibiting GSK3β, an upstream signaling molecule that upregulates Drp1 activity in diabetic conditions [31], suggesting that reducing Drp1 activity may have beneficial effects. This evidence concerns the gene DNM1L and diabetes mellitus.